Hershey has launched a new protein bar under its Reese's brand, called "One x Reese’s Peanut Butter Chocolate Flavoured Layered Protein Bar." This new product contains 18 grams of protein and two grams of sugar, aiming to appeal to consumers looking for both taste and functional performance in a snack bar. The launch leverages Hershey's earlier acquisition of high-protein snack business One Brands and its subsequent full ownership of Fulfil Nutrition's North American operations, showing a strategic move into the protein-enhanced food market.

Micron Technology, Inc. (MU) is projected to surpass its third-quarter fiscal 2026 earnings estimates due to strong demand for memory chips driven by AI servers and improving market supply-demand dynamics. The company holds a Zacks Rank #1 (Strong Buy) and has a positive Earnings ESP, further supporting the optimistic outlook. Despite potential macroeconomic headwinds and U.S.-China trade tensions, Micron's strategic positioning in AI, high-performance data centers, and diverse market segments, coupled with its discounted valuation, makes it an attractive investment ahead of its earnings report.

Jim Cramer discussed Adobe (ADBE), expressing bafflement over the stock's performance despite a "beat and raise" quarter and its low valuation. He attributed part of the problem to fierce competition and general negative sentiment towards enterprise software companies on Wall Street. Cramer advised investors to wait until the company announces new leadership (CEO and CFO) before betting on a comeback, as the current uncertainty clouds its future.

ITW GSE, a Danish ground support equipment provider, has seen significant growth due to the industry-wide shift to green technology, particularly with its electric Ground Power Unit (eGPU) solutions. The company, which phased out diesel unit manufacturing, has doubled its business in the last three years and is expanding its Odense facility. Its eGPUs offer environmental benefits and a rapid return on investment due to reduced servicing needs, and ITW GSE is innovating with power-sharing technology and integrated EcoGate systems to address charging infrastructure challenges.

Align Technology (Nasdaq: ALGN) announced that Kevin Conroy will succeed C. Raymond Larkin, Jr. as Chairman of the Board, effective July 1, 2026. Larkin, who has served for over two decades, will remain on the board through December 31, 2026, to ensure a smooth transition. Conroy brings extensive experience from his previous role as CEO of Exact Sciences before its acquisition by Abbott Laboratories.

T. Rowe Price is reshaping its distribution strategy to prioritize consultants, treating them as direct clients rather than intermediaries. This shift aims to enhance engagement and collaboration with consultants. The article highlights this new approach's potential benefits for the asset management firm.

This article provides a weekly review of C.H. Robinson stock, focusing on its performance amid a soft freight market and increased competition. It details the company's recent fundamentals, including lower revenue and operating income, and discusses its strategy of cost discipline and technology investments. The article also compares C.H. Robinson's situation with its peers and offers key company facts and stock trading details.

Delta Air Lines (DAL) will host a live conference call and webcast to discuss its second-quarter 2026 financial results on Friday, July 10, 2026, at 10 a.m. ET. Investors can access the live webcast and subsequent online replay via the company's investor relations website, ir.delta.com. This announcement provides details for shareholders and interested parties to follow the earnings disclosure.

Needham has increased its price target for Sezzle (SEZL) stock to $166 from $132, reiterating a Buy rating due to the company's strong execution in its open-loop buy-now-pay-later model. The upgrade follows impressive Q1 results, including a 37.3% year-over-year GMV growth and record 52.5% adjusted EBITDA margins, with Needham highlighting Sezzle's conservative underwriting and efficient growth strategy. Despite a significant stock surge this year, Needham believes SEZL remains undervalued compared to peers, with further upside potential driven by expanding product offerings and a new $300 million funding facility.

Sanofi's Sarclisa subcutaneous (SC) formulation has received approval in Japan for treating multiple myeloma patients, offering a less burdensome alternative to intravenous administration. This approval, based on the IRAKLIA phase 3 study, demonstrates non-inferior efficacy and pharmacokinetics. The company also anticipates Japan's first anticancer treatment potentially administered via an on-body injector, enhancing patient convenience.